Keyphrases
Nanostructured Lipid Carriers
80%
Carrageenan
50%
Alginate Microspheres
47%
Particle Size
44%
Physical Characteristics
40%
Alginate
36%
Antibacterial Activity
35%
Aerosolization
33%
Entrapment Efficiency
28%
Physical Stability
28%
Ciprofloxacin
28%
Pharmacist
26%
Indonesia
24%
P-methoxycinnamic Acid
24%
Microparticles
23%
Calcium Chloride
23%
Polymer Concentration
22%
Moisture Content
21%
Eleutherine Palmifolia
20%
Sodium Alginate
20%
Ovalbumin
20%
Self-nanoemulsifying Drug Delivery Systems (SNEDDS)
20%
Hard Shell Capsule
20%
Coenzyme Q10
20%
Quercetin
20%
Lung
19%
Swelling Index
19%
Lipids
19%
Lipid Carrier System
19%
Chitosan
19%
Liposomes
18%
Virgin Coconut Oil
18%
Surabaya
17%
Viscosity
17%
Surfactant
17%
Salicylamide
17%
Drug Loading
17%
Gelatin
17%
Solid Lipid
16%
Glutathione
16%
Alginate Dialdehyde
16%
Liquid Lipid
16%
Solid Lipid Nanoparticles
15%
Ionotropic Gelation
15%
In Vitro Release
15%
Penetration Testing
15%
κ-carrageenan
14%
Cross-linker
14%
Health Belief Model
14%
Drug Delivery System
14%
Physical Characterization
13%
Beeswax
13%
Antioxidant Activity
13%
Type 1 Diabetes Mellitus (T1DM)
13%
Alginate Concentration
13%
Emulgel
12%
Maltodextrin
12%
Delivery System
12%
Pulmonary Delivery
12%
Skin Penetration
12%
Nanoemulsion
12%
Physicochemical Characteristics
12%
Sargassum Plagiophyllum
12%
Primaquine
12%
Fucoidan
12%
Ursolic Acid
12%
Peel-off
12%
Chloroquine
12%
Partition Coefficient
12%
Meloxicam
12%
Solid Lipid Microparticles
12%
Amniotic Mesenchymal Stem Cells
12%
Patient Compliance
11%
Patient Adherence
11%
Tween 80
11%
Physical Properties
10%
Sorbitol
10%
Release Profile
10%
Lipid Ratios
10%
Cacao
10%
Hypertension Management
10%
Tomato Paste
10%
Olea
10%
Cutibacterium Acnes (C. acnes)
10%
Bovine Hydroxyapatite
10%
Release Rate
9%
Polyethylene Glycol
9%
Lactobacillus Acidophilus
9%
Physicochemical Properties
9%
Chitosan-hydroxyapatite
9%
Behavioral Factors
9%
Ionic Gelation
9%
Cocos nucifera
9%
Drug Release
9%
Organoleptic
9%
Hydrophilic-lipophilic Balance
9%
Inhalation
9%
Diabetes Mellitus Patients
9%
Diabetes Mellitus Treatment
9%
Metformin
8%
Pharmacology, Toxicology and Pharmaceutical Science
Microsphere
100%
Alginic Acid
93%
Carrageenan
56%
Chitosan
36%
Drug Delivery System
34%
Ciprofloxacin
33%
Surfactant
31%
Microparticle
30%
Diabetes Mellitus
27%
Antibacterial Activity
25%
Gelatin
24%
Quercetin
24%
Drug Release
23%
Liposome
22%
Ovalbumin
18%
Antiinfective Agent
18%
Coconut Oil
18%
Salicylamide
17%
Calcium Chloride
17%
Solid Lipid Nanoparticle
16%
Ubidecarenone
16%
Nanoemulsion
16%
Glutathione
16%
Epigallocatechin Gallate
16%
Vegetable Oil
15%
Diseases
14%
Antioxidant Capacity
13%
Buffer
13%
Antioxidant
13%
Miglyol
13%
Nanoparticle
12%
Tween 80
12%
Pharmacotherapy
12%
Randomized Controlled Trial
12%
Primaquine
12%
Coconut
12%
Implant
12%
Chloroquine
12%
Diclofenac
12%
Ursolic Acid
12%
Meloxicam
12%
Polyvinyl Alcohol
12%
Maltodextrin
11%
Theobroma Oil
11%
Sorbitol
11%
Anti-Inflammatory Drug
10%
Palmitic Acid
10%
Glycerol Monostearate
10%
Scanning Electron Microscopy
10%
Zeta Potential
10%
Non Insulin Dependent Diabetes Mellitus
10%
Dosage Forms
10%
Hydroxyapatite
9%
Cross-Sectional Study
9%
Cosmetic
9%
Hydroxypropylmethylcellulose
9%
Drug Information
9%
Chronic Disease
8%
Wound Healing
8%
Metformin
8%
Hydrophilic-Lipophilic Balance
8%
Peppermint Oil
8%
Oral Antidiabetic Agent
8%
Ubiquinone
8%
Plasticizer
8%
Plantar Ulcer
8%
Aleurites
8%
Niosome
8%
Alpha Tocopherol
8%
Photoaging
8%
Cosurfactant
7%
Antibiotics
7%
Glutaraldehyde
7%
Erythropoietin
7%
Propylene Glycol
7%
Micelle
6%
Controlled Release
6%
Ulcer
6%
Malignant Neoplasm
6%
Bioavailability
6%
Macrogol 400
6%
Transdermal
6%
Respiratory Tract Infection
6%
Combination Therapy
6%
Stearate
6%
Flavonoid
6%
Propionibacterium acnes
6%
Glycerol Behenate
5%
Polymer Ratio
5%
Interstitial Collagenase
5%
Macrogol
5%
Staphylococcus Aureus
5%
Gentamicin
5%
Base
5%
Egg Lecithin
5%
Gelling Agent
5%
Fatty Acid
5%